BioHealth News Archive

2012 BIO International Convention to Highlight the FDA and Regulatory Environment

2012 BIO International Convention to Highlight the FDA and Regulatory Environment

The U.S. regulatory environment strongly impacts innovation and the development of new drugs and biologics. With this in mind, the Achieving Regulatory Approval and…

Read More
Ablitech Hires Director for Research Advisory Board

Ablitech Hires Director for Research Advisory Board

Ablitech, Inc., a biotechnology company developing delivery systems for gene silencing and cancer-fighting treatments, today announced that Dr. Daniel Bednarik has been named the…

Read More
Health Data Initiative Forum

Health Data Initiative Forum

Plug into the Ecosystem of Health Innovation. Bring creative ideas, and connect with startups, developers, and designers. Learn how to utilize the exploding market…

Read More
RHT Consulting to Come Up with Steps to Spur Research at NIH

RHT Consulting to Come Up with Steps to Spur Research at NIH

Right now there are probably thousands of late-stage cancer patients waiting for drugs that could prolong their lives. Where do they look? Research labs all across…

Read More
Johns Hopkins secures $15M NIH grant for AIDs research center

Johns Hopkins secures $15M NIH grant for AIDs research center

The National Institutes of Health announced Friday it has awarded Johns Hopkins University $15 million to help establish the school’s new Center for AIDS…

Read More
Federal Telemedicine News: Moving Research Forward

Federal Telemedicine News: Moving Research Forward

TATRC within the Army’s Medical Research and Materiel Command is taking steps to move research forward according to the article “TATRC: Translating Research into…

Read More
GlaxoSmithKline makes hostile Human Genome Sciences bid – Washington Business Journal

GlaxoSmithKline makes hostile Human Genome Sciences bid – Washington Business Journal

GlaxoSmithKline PLC is taking its unsolicited $2.6 billion bid for Rockville-based Human Genome Sciences Inc.    directly to the biotech's shareholders through a tender…

Read More
National Heart, Lung and Blood Institute to Establish NHLBI Centers for Accelerated Innovations

National Heart, Lung and Blood Institute to Establish NHLBI Centers for Accelerated Innovations

The National Heart, Lung, and Blood Institute (NHLBI) published a Funding Opportunity Announcement (FOA) in the Spring 2012 NIH Guide for Grants and Contracts…

Read More
We Can’t Wait Update: Advancing Innovation in Health Care | The White House

We Can’t Wait Update: Advancing Innovation in Health Care | The White House

From the electric light bulb to the Internet, American innovations have made lives better for people in this country and all over the world.…

Read More
We Can’t Wait: HHS announces first 26 Health Care Innovation awards

We Can’t Wait: HHS announces first 26 Health Care Innovation awards

Health and Human Services (HHS) Secretary Kathleen Sebelius today announced the first batch of organizations for Health Care Innovation awards. Made possible by the…

Read More

Breaking the Genome Bottleneck – Technology Review

The genomic data generated from next-generation sequencing machines doesn't amount to much more than alphabet soup if it's not subjected to significant computational processing…

Read More
Supernus moves from IPO to FDA – Washington Business Journal

Supernus moves from IPO to FDA – Washington Business Journal

Supernus Pharmaceuticals Inc. capped off its first week on the Nasdaq up nearly $1 from its initial public offering price. With its IPO in…

Read More
State biotech firms hoping Congress will act – baltimoresun.com

State biotech firms hoping Congress will act – baltimoresun.com

A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based in Maryland — hoping…

Read More

Should the FDA Approve More Drugs after Phase II? A Response to Matthew Herper – Forbes

Last Friday, Forbes health care editor Matt Herper and I sat down to talk about my proposal, which I detailed in a paper for…

Read More
Biotech Venture Funding Drops 43% in First Quarter | McDonnell Boehnen Hulbert & Berghoff LLP – JDSupra

Biotech Venture Funding Drops 43% in First Quarter | McDonnell Boehnen Hulbert & Berghoff LLP – JDSupra

Last month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report…

Read More